The Official Journal of the Turkish Society Of Clinical Microbiology and Infectious Diseases (KLİMİK)

Original Article

Filter Newest Oldest Showing 41-60 of 121 results
Original Article / VOLUME 5, ISSUE 2, JUNE 2023

COVID-19 Among Patients with Psoriasis: A Single-Center Retrospective Cross-Sectional Study

Özge Kaya and others

Psoriasis, a chronic inflammatory disease, has a multifactorial etiology, including genetic, environmental, and behavioral factors. Since psoriasis is an immune system-mediated disease, immunosuppressive agents and biological treatments are frequently used in its treatment; however, these agents are known to increase the risk of infection. This situation (...) Read More

Original Article / VOLUME 5, ISSUE 2, JUNE 2023

Change in Rates of HBsAg and Anti-HBs in Şırnak 20 Years After Introduction of Hepatitis B Vaccine into Routine Infant Immunization Program

Meyha Şahin and Meltem Yazla

Chronic hepatitis B virus (HBV) infection is a serious public health problem affecting 257 million people worldwide (3.5% of the world population), according to World Health Statistics 2015 by the World Health Organization (WHO). In Turkey, approximately 3.3 million people (4.57% of the population) are considered HBsAg (hepatitis B surface antigen) positive (...) Read More

Original Article / VOLUME 5, ISSUE 2, JUNE 2023

Hypochlorous Acid: A Novel Agent Against Echinococcus granulosus Protoscoleces

Oruç Numan Gökçe and others

Many parts of the world are affected by Echinococcus granulosus. This helminthic zoonosis leads to important public health and economic burdens in endemic regions. E. granulosus can even lead to death if complications occur. Dogs are the definitive hosts of E. granulosus, where the larval state, (...) Read More

Original Article / VOLUME 5, ISSUE 1, MARCH 2023

Evaluation of Inflammation-Based Prognostic Risk Scores in Predicting in-Hospital Mortality Risk in COVID-19 Patients: A Cross-Sectional Retrospective Study

Çaşıt Olgun Çelik and others

An acute respiratory syndrome (COVID-19), caused by a novel coronavirus (SARS-CoV-2), has spread from China worldwide and caused a pandemic that brought severe medical, social, and economic problems. The COVID-19 infection results in various clinical presentations ranging from an asymptomatic (...) Read More

Original Article / VOLUME 5, ISSUE 1, MARCH 2023

Fournier’s Gangrene: Microbiological Profile and Risk Factors for Mortality: Review of 97 Cases

Aynur Atilla and others

Fournier’s gangrene (FG) is necrotizing fasciitis of genital or perianal areas. Typically, FG is an infection of polymicrobial origin and has higher mortality rates if treatment is not initiated earlier. The main etiological factors are colorectal (30%-50%) and genitourinary origins (20%-40%), including anorectal infections, (...) Read More

Original Article / VOLUME 5, ISSUE 1, MARCH 2023

Evaluation of Clinical Approach and Outcomes Staphylococcus aureus Bacteremia

Tuğba Yanık-Yalçın and others

Staphylococcus aureus colonizes the skin and mucosa of humans. Infections because of S. aureus can range from skin infections to potentially fatal conditions like pneumonia, sepsis, and endocarditis. S. aureus is a common cause of nosocomial and community-acquired bloodstream infections worldwide. Because of biofilm (...) Read More

Original Article / VOLUME 5, ISSUE 1, MARCH 2023

Ophthalmologic Examination and Echocardiography Should be the Essential Components of Candidemia Bundle

Çiğdem Erol and others

Candida species are major sources of morbidity and mortality in healthcare settings. These infections are predominantly connected with medical procedures. The five most prevalent pathogens- Candida albicans, Candida glabrata, Candida tropicalis, Candida parapsilosis, and Candida krusei – are responsible for (...) Read More

Original Article / VOLUME 4, ISSUE 4, DECEMBER 2022

Thyroid Dysfunction among the Patients with Critical COVID-19

Hande Özportakal and others

The world has been fighting against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for more than two years, leading to more than 605 million cases and 6.4 million deaths as of September 11, 2022. Since the angiotensin-converting enzyme (ACE) is the functional receptor for SARS-CoV-2, predominantly expressed by the alveoli (...) Read More

Original Article / VOLUME 4, ISSUE 4, DECEMBER 2022

Analysis of the Prophylactic use of Hydroxychloroquine at the Beginning of the COVID-19 Pandemic Among Physicians

Mehmet Gökhan Gönenli and others

Healthcare workers were on the front line of the global effort against COVID-19. Thousands of physicians died from COVID-19 in many countries. In addition, difficulties in accessing personal protective equipment (PPE), lack of training, and workforce shortages have exposed the vulnerability of healthcare workers who desperately sought other options to protect (...) Read More

Original Article / VOLUME 4, ISSUE 4, DECEMBER 2022

Comparison of CURB-65 Pneumonia Severity Score, Quick COVID-19 Severity Index, and Brescia-COVID Respiratory Severity Scale in Emergently Hospitalized COVID-19 Patients with Pneumonia

İbrahim Toker and others

Coronavirus disease 2019 (COVID-19) occurred with different levels of severity, and different criteria for hospitalizations were suggested, considering risk factors for poor outcomes, such as advanced age, comorbidities, lymphopenia, and high C-reactive protein (CRP) levels. The most severe complication of COVID-19 is viral pneumonia, which is often manifested by diffuse bilateral lung (...) Read More

Original Article / VOLUME 4, ISSUE 4, DECEMBER 2022

Prevalence of Fosfomycin Resistance Among Enterobacterales Isolates in A Tertiary Care Hospital from Turkey

Yeliz Tanrıverdi-Çaycı and others

Urinary tract infections (UTIs) are seen in all age groups and are among the most frequent bacterial infections. Enterobacterales are the most common bacterial species that cause UTIs . Escherichia coli is the most common cause of both complicated UTIs (65%) and uncomplicated UTIs (75%). E. coli is followed by other Enterobacterales such as Klebsiella spp., Proteus spp., and Serratia spp. Resistance of urinary tract pathogens to (...) Read More

Original Article / VOLUME 4, ISSUE 4, DECEMBER 2022

Stenotrophomonas maltophilia Bacteremia: From Diagnosis to Treatment

Pınar Aysert-Yıldız and others

Stenotrophomonas maltophilia is an aerobic, non-fermentative, Gram-negative bacterium widespread in aquatic environments and soil. It has an inherent ability to adhere to abiotic surfaces and forms biofilms. It is usually considered to be a commensal and a low-grade pathogen. However, it can cause severe infections in the immunocompromised and debilitated (...) Read More

Original Article / VOLUME 4, ISSUE 4, DECEMBER 2022

Prospective Evaluation of Infections in Geriatric Patients in Intensive Care Units

Hasan Naz and others

Nosocomial infections (NIs) constitute a major health issue in terms of morbidity, high mortality, prolonged hospitalization, and increased costs of direct patient care. While beds in intensive care units (ICUs) constitute less than 10% of all hospital beds, more than 20% of all NIs develop in the ICU. The human lifespan has been prolonged (...) Read More

Original Article / VOLUME 4, ISSUE 4, DECEMBER 2022

Evaluation of Blood Stream and Biliary Tract Infections Related to Percutaneous Transhepatic Cholangiography and Prophylaxis Given in Patients with Malignancy

Halime Araz and others

Percutaneous transhepatic cholangiography (PTC) is an invasive procedure used in patients with obstructive jaundice in the progress of some malignancies to reduce bilirubin levels, improve liver functions, prolong survival and enable other treatments. The procedure is critical because of its potential complications. The most common (...) Read More

Original Article / VOLUME 4, ISSUE 3, SEPTEMBER 2022

Maternal Stress and Neonatal Nutrition during the COVID-19 Era

Alara Altıntaş and others

COVID-19 has been the main focus of the world since the beginning of 2020. The virus has infected over 180 million people and caused about 6 million deaths worldwide up to February of 2022. With its rapid spread, the new coronavirus posed enormous economic, environmental, and social challenges together with health threats to the entire (...) Read More

Original Article / VOLUME 4, ISSUE 3, SEPTEMBER 2022

The Effect of the Pandemic on Antifungal Use: What Has Changed?

Vildan Avkan-Oğuz and others

Before coronavirus disease 2019 (COVID-19), antimicrobial stewardship (AMS) programs were essential for managing multidrug-resistant Gram-negative bacterial infections. In contrast, antifungal stewardship (AFS) programs were uncommon as a component of AMS. During the COVID-19 pandemic, both AMS and AFS programs have lost (...) Read More

Original Article / VOLUME 4, ISSUE 3, SEPTEMBER 2022

Cognitive Assessment of Young Adults Before and After Initiation of Combination Antiretroviral Therapy

Özlem Gül and others

The presence of cognitive disorders in the human immunodeficiency virus (HIV) infected individuals has been known for a long time. A complete neuropsychological evaluation method is a gold standard for diagnosing HIV-related cognitive impairment (HAND). However, such tests require specially trained personnel and specialized centers, and testing takes a long time. Montreal Cognitive (...) Read More